Article ID Journal Published Year Pages File Type
3332169 Hematology/Oncology Clinics of North America 2007 16 Pages PDF
Abstract

Blood transfusion utilization continues to rise, yet it has never undergone prospective safety and efficacy testing. Recent data regarding oxygen delivery, microcirculation, and inflammation all point toward potential problems with allogeneic transfusion. Outcome data from retrospective data bases are sobering, calling to question the present practices of red cell transfusion.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
,